Literature DB >> 165257

Separation of antigen-specific lymphocytes. II. Enrichment of hapten-specific antibody-forming cell precursors.

W Haas.   

Abstract

Normal spleen cells were separated in dishes coated with thin layers of DNP-gelatin or NIP-gelatin into binding and nonbinding cells and stimulated in vitro with DNP- and/or NIP-conjugated polymerized flagellin (POL). Hapten-specific unresponsiveness was induced in the binding cell population by melting the gel at 37 degrees C or in unfractionated cells by pretreatment with soluble hapten-gelatin and could be reversed by treatment with collagenase. A specific enrichment of anti-DNP and anti-NIP antibody-forming cell precursors (AFCP) could be demonstrated in the binding cell populations after treatment with collagenase in cultures with or without "feeder" cells. However, the response of small numbers of unfractionated and purified hapten-specific spleen cells was suboptimal even in the presence of mitomycin-treated or irradiated feeder cells. Optimal numbers of anti-DNP (anti-NIP) antibody-forming cells were generated by small numbers of normal or purified spleen cells in the presence of spleen cells depleted of anti-DNP (anti-NIP) AFCP. In this system the response of only 2 times 10-4 purified hapten-specific cells was higher than the response of 10-6 unfractionated cells. Purified DNP-specific cells responded only to DNP-POL but not to NIP-POL and purified NIP-specific cells responded only to NIP-POL but not to DNP-POL. The degree of enrichment of anti-DNP AFCP decreased with increasing numbers of binding cells. NIP3-gelatin layers bound four to five times less spleen cells than DNP2-gelatin layers and the enrichment of anti-NIP AFCP (about 300-fold) was three times greater than the enrichment of anti-DNP AFCP (about 100-fold). The immunological significance of hapten-gelatin binding cells which apparently failed to respond to antigen is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165257      PMCID: PMC2189794          DOI: 10.1084/jem.141.5.1015

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  A new, simple method for the preparation of lymphocytes bearing specific receptors.

Authors:  W Haas; J W Schrader; A Szenberg
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

2.  Cell fractionation on affinity columns. In vivo function of hemocyanin-binding lymphocytes from normal mouse spleen.

Authors:  L A Moroz; A O Kotoulas
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

3.  Thymus-derived rosettes are not "helper" cells.

Authors:  B E Elliott; J S Haskill; M A Axelrad
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

4.  Regulation of antibody response in vitro. IV. Heavy chain antigenic determinants on hapten-specific memory cells.

Authors:  T Kishimoto; K Ishizaka
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

5.  Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter.

Authors:  M H Julius; T Masuda; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

6.  Induction of immunity and tolerance to the dinitrophenyl determinant in vitro.

Authors:  M Feldmann
Journal:  Nat New Biol       Date:  1971-05-05

7.  Immunological tolerance in bone marrow-derived lymphocytes. II. Effects of allogeneic cell interactions and enzymatic digestion with trypsin or inactivated hapten-specific precursors of antibody-forming cells.

Authors:  T Hamaoka; D H Katz
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

8.  Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin.

Authors:  S Fuchs; E Mozes; A Maoz; M Sela
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

9.  Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or "nonimmunogenic" carriers.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized.

Authors:  G W Siskind; W E Paul; B Benacerraf
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

View more
  8 in total

1.  Estimation of hapten-specific antibody-forming cell precursors in microcultures.

Authors:  J W Stocker
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

2.  Functional maturation of B cells in vitro.

Authors:  J W Stocker
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

3.  Single cell studies on the antibody-forming potential of fractionated, hapten-specific B lymphocytes.

Authors:  G J Nossal; B L Pike
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

4.  Enrichment of antigen-specific B lymphocytes by the direct removal of B cells not bearing specificity for the antigen.

Authors:  S M Walker; G C Meinke; W O Weigle
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

5.  Requirement for persistent extracellular antigen in cultures of antigen-binding B lymphocytes.

Authors:  B L Pike; G J Nossal
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

6.  Antifluorescein affinity columns. Isolation and immunocompetence of lymphocytes that bind fluoresceinated antigens in vivo or in vitro.

Authors:  D W Scott
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

7.  Antigen-induced aggregation and modulation of receptors on hapten-specific B lymphocytes.

Authors:  G J Nossal; J E Layton
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

8.  Definition of conditions that enable antigen-specific activation of the majority of isolated trinitrophenol-binding B cells.

Authors:  J C Cambier; J G Monroe; M J Neale
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.